Temporal trends in the prevalence of diabetic kidney disease in the United States - Wikidata - awgldk - TriplyDB

Temporal trends in the prevalence of diabetic kidney disease in the United States

Temporal trends in the prevalence of diabetic kidney disease in the United States

http://www.wikidata.org/entity/Q37064114

about

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association Systemic nutritional interventions for treating foot ulcers in people with diabetes Direct renin inhibitors for preventing the progression of diabetic kidney disease Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes FRMD3 gene: its role in diabetic kidney disease. A narrative review Translational research in nephrology: chronic kidney disease prevention and public health Non-Proteinuric Diabetic Nephropathy Ethnic/Race Diversity and Diabetic Kidney Disease Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade Perspectives on systems biology applications in diabetic kidney disease Type 2 translational research for CKD Kidney disease: new technologies translate mechanisms to cure Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes Diabetic kidney disease: a report from an ADA Consensus Conference Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Tooth loss strongly associates with malnutrition in chronic kidney disease Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease)Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial New susceptibility loci associated with kidney disease in type 1 diabetes.Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart disease and stroke statistics--2012 update: a report from the American Heart Association Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015 Renal lesions in patients with type 2 diabetes: a puzzle waiting to be solved.Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis The effects of glucose-lowering therapies on diabetic kidney disease Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey.Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease.Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease Cardiovascular complications of diabetic kidney disease.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cells Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative Annual deterioration of renal function in hypertensive patients with and without diabetes.Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.

P2860

Q22306356-C66B2FD2-900D-44AD-9F94-5CE926D37A6C Q24188236-8EF19368-5F5D-44E5-A3D9-19BC14FA7C5C Q24198989-49A7D577-E761-490B-B458-20DC5EC0D256 Q26741423-5984C953-6473-4F4A-B50A-4EE84C27E153 Q26741451-F2E0C782-57B0-4436-B490-02108199293D Q26744419-8D22D9B8-EBA0-46CA-9A48-50E4595433BC Q26771495-DAED78A7-75B5-4F98-B703-B483A68408C2 Q26776395-46CA1637-7599-40FA-95AE-C22D2355691B Q26786923-E4D58ADA-F3A8-488C-9FC2-C7018CCA9FBD Q26796594-9BDB1CFC-DD3D-4C67-A629-682F29E1F24A Q26799443-E3DE15FC-7371-4591-813C-A7D8A227E531 Q26823206-6AF6BB14-FAE9-4D5C-96DE-20C311A74F4C Q26823511-FBEBD55A-B2A9-4832-A226-E86D90B15358 Q26825227-72ADFF8B-0919-4138-A833-50402E44F087 Q27004274-B176E1A4-B151-44A0-A414-56082E853252 Q27012546-6354F259-E0FA-4B6F-A23D-7A179FDFB58F Q27687851-16A4206C-C73C-4508-82A4-1CD53A765278 Q28301679-78D834B1-7DC6-4080-B346-79605FB990CC Q28545206-E01740F8-3A83-436E-9037-4AEADD7CF06C Q28546969-962D8993-9353-4118-AB7C-D1D126D62C76 Q29417066-06669C5D-DCE6-49C9-BD07-4A11536C448A Q29547691-42ABBB01-F148-40A4-B1C1-8088D3E2533A Q29547909-1110264D-0563-4347-95F8-CC78EAA89CAE Q31146511-A8D1B07E-1E6E-4EF5-A958-2F6498B995F1 Q33359672-C58B85ED-6273-4462-BA9B-2E9F16D9C5DA Q33559001-6719D5F9-5F99-4304-99FE-1FFF39008293 Q33583018-61FE47C0-E80F-400F-B66C-0B8CC695A933 Q33583220-414D75C4-E1B8-4F39-8B1B-2BE3C3ED4EFB Q33612502-3A5E08A6-2473-4056-9C09-DD7DAB76AF38 Q33623998-CCFA5656-A9DD-41B0-8166-0376BFB5E648 Q33698333-12D80F35-0617-4245-BAE7-4E954F475E17 Q33698768-23A8BFFD-3035-49A8-B02D-47E40CBB4DE3 Q33711038-436B4D6A-1837-4590-8472-E694583BDC30 Q33741426-D5B10A1E-9B56-4C95-99F3-138360D1B75F Q33744838-AF069389-0E25-4895-89D8-B3A2A0E6E311 Q33776181-2D7CCB23-D739-450B-BF20-88E8CFE16DA4 Q33789640-952D23DB-230F-4998-847A-19CA208FAAAF Q33875371-307E136F-259B-40EE-8C64-DEF66BE26203 Q33899286-B2257988-4155-4A83-8957-6347140B100D Q33902878-5976F0BD-0787-4B66-BB47-6E4D6147A76A

P2860

Temporal trends in the prevalence of diabetic kidney disease in the United States

http://www.wikidata.org/entity/Q37064114

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Temporal trends in the prevalence of diabetic kidney disease in the United States

@en

Temporal trends in the prevalence of diabetic kidney disease in the United States.

@nl

type

label

Temporal trends in the prevalence of diabetic kidney disease in the United States

@en

Temporal trends in the prevalence of diabetic kidney disease in the United States.

@nl

prefLabel

Temporal trends in the prevalence of diabetic kidney disease in the United States

@en

Temporal trends in the prevalence of diabetic kidney disease in the United States.

@nl

P1433

Q37064114-9F2DA147-6745-45DE-9E54-630D827A1B59

P1476

Q37064114-20912746-F6AC-4E70-A029-1F5A04361691

P2093

Q37064114-43FFEB8A-9794-4B29-8EBA-79711CA959D0

Q37064114-732D471B-321D-4B99-B4B8-A1247BEF1D72

Q37064114-7C3BFF51-55B6-4576-89F0-4A49568CB74B

Q37064114-9029639F-1438-452B-8D60-8B0375116D53

Q37064114-92F162F8-4418-49B4-8C73-E55682D7D8F6

Q37064114-CC9E3940-710E-48AD-ABBD-8EC025DE182D

P2860

Q37064114-14B344BC-9D07-4CE1-AA90-96FFB0E2A9EE

Q37064114-170003F4-B2C1-4940-AE8D-365A8C1F176B

Q37064114-1D8B366E-45AA-44EA-8B62-81F9090C0E86

Q37064114-21AA9449-0779-4D94-BD74-E0ED7887C447

Q37064114-2A476D2E-8E2F-4768-A7BE-2934978D7EB0

Q37064114-2E3FD6C2-9DF4-43E0-B942-7DCD4E63618D

Q37064114-365F509D-E985-472E-AF87-1DB3020F5126

Q37064114-3C8CF9CE-9A67-4AA3-B47A-F8FB433E3AAE

Q37064114-41F94259-67DC-446C-8499-627F883BA994

Q37064114-46DD9E53-AD85-4DFF-AEDA-57216E69552A

P304

Q37064114-35C50D2D-618A-4ED7-B363-EDF6A7C87357

P31

Q37064114-06991672-4F38-498F-98D0-9DFA3089385C

P356

Q37064114-B5BA8455-1D21-4DFF-9527-5A8CE8FA5FBF

P407

Q37064114-E12D6BF7-1374-4E92-A1E6-F002FB7C1FAA

P433

Q37064114-0C714FEA-C3AE-4154-9C85-6093A5BE8B70

P478

Q37064114-F02A2C7A-1A29-4DBF-AB8B-289F08932ACA

P577

Q37064114-6146E131-43C5-4889-8EE3-501BCE90EDC6

P5875

Q37064114-13244E76-E061-4A5B-8BBE-DD1EAB01AF2B

P698

Q37064114-6CEA7BF9-7305-4950-8D4C-DC29080534BB

P921

Q37064114-08F14DE1-9A34-48F4-9595-D4C514046D1F

P932

Q37064114-3AB625D6-42C3-4AB8-9A79-78B91549B667

P356

P1433

Journal of the American Medical Association

P1476

Temporal trends in the prevalence of diabetic kidney disease in the United States

@en

P2093

Ian H de Boer

http://www.w3.org/2001/XMLSchema#string

Jonathan Himmelfarb

http://www.w3.org/2001/XMLSchema#string

Noel S Weiss

http://www.w3.org/2001/XMLSchema#string

Patrick J Heagerty

http://www.w3.org/2001/XMLSchema#string

Tessa C Rue

http://www.w3.org/2001/XMLSchema#string

Yoshio N Hall

http://www.w3.org/2001/XMLSchema#string

P2860

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

A new equation to estimate glomerular filtration rate

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Prevalence of chronic kidney disease in the United States

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done?

Standards of medical care in diabetes--2010.

P304

2532-2539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.861

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51238922

http://www.w3.org/2001/XMLSchema#string

P698

21693741

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3731378

http://www.w3.org/2001/XMLSchema#string